Growth Metrics

Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026)

Koninklijke Philips' quarterly Net Income towards Common Stockholders came in at $187319.3 in Q1 2026, up 122.6% year-on-year from $84150.8 in Q1 2025, and down 60.75% quarter-over-quarter from $477257.8 in Q4 2025.

Koninklijke Philips has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $187319.3 in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 122.6% year-over-year to $187319.3; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 175.26% YoY), and the FY2025 full-year result was $477257.8, up 227.61% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $187319.3, down from $477257.8 in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $506137.2 in Q2 2024, with the low at -$1.5 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$155957.5, with a median of $76224.7 recorded in 2023.
  • Year-over-year, Net Income towards Common Stockholders tumbled 495.44% in 2022 and soared 564.01% in 2024.
  • Tracing PHG's Net Income towards Common Stockholders over 5 years: stood at -$112227.2 in 2022, then slumped by 369.77% to -$527210.6 in 2023, then advanced by 29.06% to -$374008.4 in 2024, then surged by 227.61% to $477257.8 in 2025, then tumbled by 60.75% to $187319.3 in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $187319.3 (Q1 2026), $477257.8 (Q4 2025), and $222120.5 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 238.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 187,319.30
Dec 31, 2025 477,257.84
Sep 30, 2025 222,120.47
Jun 30, 2025 282,989.92
Mar 31, 2025 84,150.76
Dec 31, 2024 -374,008.39
Sep 30, 2024 208,661.71
Jun 30, 2024 506,137.16
Mar 31, 2024 -1.16 Mn
Dec 31, 2023 -527,210.56
Sep 30, 2023 97,973.14
Jun 30, 2023 76,224.71
Mar 31, 2023 -772,806.11
Dec 31, 2022 -112,227.21
Sep 30, 2022 -1.45 Mn
Jun 30, 2022 -202,740.77
Mar 31, 2022 -190,797.41
Dec 31, 2021 4.20 Mn
Sep 30, 2021 4.10 Mn
Jun 30, 2021 204,726.14
Mar 31, 2021 48,249.44
Dec 31, 2020 1.56 Mn
Sep 30, 2020 432,188.58
Jun 30, 2020 253,335.83
Mar 31, 2020 44,157.56
Dec 31, 2019 675,201.48
Sep 30, 2019 734,401.82
Jun 30, 2019 292,146.16
Mar 31, 2019 204,593.20
Dec 31, 2018 1.35 Mn
Sep 30, 2018 523,408.13
Mar 31, 2018 171,994.59
Dec 31, 2017 2.10 Mn
Sep 30, 2017 1.01 Mn
Jun 30, 2017 571,765.65
Mar 31, 2017 -13.39 Bn
Dec 31, 2016 675.91 Mn
Sep 30, 2016 412.99 Mn
Jun 30, 2016 474.55 Mn
Mar 31, 2016 35.30 Mn
Dec 31, 2015 -49.33 Mn
Sep 30, 2015 354.82 Mn
Jun 30, 2015 300.60 Mn
Mar 31, 2015 111.85 Mn
Dec 31, 2014 173.73 Mn
Sep 28, 2014 -14.50 Bn
Jun 29, 2014 -14.74 Bn
Mar 30, 2014 -15.09 Bn
Dec 31, 2013 -15.26 Bn
Sep 29, 2013 -14.46 Bn
Jun 30, 2013 -14.06 Bn
Mar 31, 2013 212.58 Mn
Dec 31, 2012 -548.59 Mn
Sep 30, 2012 130.06 Mn
Jun 30, 2012 533.25 Mn
Mar 31, 2012 238.66 Mn
Dec 31, 2011 -1.81 Bn
Sep 30, 2011 104.68 Mn
Jun 30, 2011 -1.74 Bn
Mar 31, 2011 -125.81 Mn
Dec 31, 2010 628.74 Mn
Sep 30, 2010 676.63 Mn
Jun 30, 2010 330.18 Mn
Mar 31, 2010 276.94 Mn
Dec 31, 2009 -20.70 Bn
Sep 27, 2009 -19.06 Bn
Jun 28, 2009 -18.13 Bn
Mar 29, 2009 -19.85 Bn